RTI Health Solutions   Report issue

For profit Phase 3
Founded: Durham NC United States (2001)

Organization Overview

First Clinical Trial
2006
NCT00454688
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2017

Timeline

NOW
  • Now

Alternative names

RTI health solutions, US

Active Ingredients

Drugs in Phase 3 Trials (1)

asimadoline (3 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Diarrhea (Phase 3)

Ileus (Phase 2)

Irritable Bowel Syndrome (Phase 3)

Syndrome (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 3
  • # of Trial APIs: 1